C25.9 Malignant neoplasm of pancreas, unspecified

✓ Billable ICD-10-CM 2026
Open C25.9 in Web App →

The ICD-10-CM code for Malignant neoplasm of pancreas, unspecified is C25.9 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
C15-C26: Malignant neoplasms of digestive organs (C15-C26)
Category C25
9 codes (8 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C25.9:

  • Carcinoma (malignant) › islet cell › with exocrine, mixed › unspecified site
  • Adenocarcinoma › islet cell › with exocrine, mixed › unspecified site

U.S. Hospital Utilization

  • An estimated 69,870 U.S. inpatient stays in 2023 included C25.9 among the documented diagnoses.
  • 14,920 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Ectopic tissue malignancy: code to site of origin (example C25.9)

Malignant neoplasm of ectopic tissue Malignant neoplasms of ectopic tissue are to be coded to the site of origin mentioned, e.g., ectopic pancreatic malignant neoplasms involving the stomach are coded to malignant neoplasm of pancreas, unspecified (C25.9).

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2
Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial